Acrivon Stock Analysis

ACRV
 Stock
  

 12.43  0.42  3.27%   

The latest price climb of Acrivon Therapeutics, could raise concerns from sophisticated investors as the firm is trading at a share price of 12.43 on 3,030 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in January. The stock standard deviation of daily returns for 90 days investing horizon is currently 289.35. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Acrivon Therapeutics, partners.
Please continue to Trending Equities.
  
The Acrivon Therapeutics, stock analysis report makes it easy to digest most publicly released information about Acrivon Therapeutics, and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Acrivon Stock analysis module also helps to analyze the Acrivon Therapeutics, price relationship with some important fundamental indicators such as market cap and management efficiency.

Acrivon Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. For more info on Acrivon Therapeutics, please contact the company at 617 207 8979 or go to https://www.acrivon.com.

Acrivon Therapeutics, Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acrivon Therapeutics,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acrivon Therapeutics, or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Acrivon Therapeutics, is way too risky over 90 days horizon
Acrivon Therapeutics, appears to be risky and price may revert if volatility continues
Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 0.
About 13.0% of the company shares are held by company insiders

Acrivon Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 265.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acrivon Therapeutics,'s market, we take the total number of its shares issued and multiply it by Acrivon Therapeutics,'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Acrivon Therapeutics, management efficiency ratios could be used to measure how well acrivon therapeutics, manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, Acrivon Therapeutics, shows the mean deviation of 2.542220727E7, and Risk Adjusted Performance of 0.4398. Acrivon Therapeutics, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Acrivon Therapeutics,, which can be compared to its rivals. Please confirm Acrivon Therapeutics, standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Acrivon Therapeutics, is priced correctly, providing market reflects its regular price of 12.43 per share. Given that Acrivon Therapeutics, has jensen alpha of 1.386665015E7, we suggest you to validate Acrivon Therapeutics,'s prevailing market performance to make sure the company can sustain itself at a future point.

Acrivon Therapeutics, Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Acrivon Therapeutics, Triple Exponential Moving Average indicator shows smoothing effect of Acrivon Therapeutics, price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
.

Acrivon Therapeutics, Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acrivon Therapeutics, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acrivon Therapeutics,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acrivon Therapeutics, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acrivon Therapeutics, Predictive Daily Indicators

Acrivon Therapeutics, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Acrivon Therapeutics, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Acrivon Therapeutics, Forecast Models

Acrivon Therapeutics, time-series forecasting models is one of many Acrivon Therapeutics,'s stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Acrivon Therapeutics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Acrivon Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Acrivon Therapeutics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acrivon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Acrivon Therapeutics,. By using and applying Acrivon Stock analysis, traders can create a robust methodology for identifying Acrivon entry and exit points for their positions.
Acrivon Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Acrivon Therapeutics, to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module
Please continue to Trending Equities. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for analysis

When running Acrivon Therapeutics, price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Acrivon Therapeutics,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acrivon Therapeutics,. If investors know Acrivon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acrivon Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
265.7 M
The market value of Acrivon Therapeutics, is measured differently than its book value, which is the value of Acrivon that is recorded on the company's balance sheet. Investors also form their own opinion of Acrivon Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Acrivon Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acrivon Therapeutics,'s market value can be influenced by many factors that don't directly affect Acrivon Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acrivon Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine Acrivon Therapeutics, value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acrivon Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.